CHIESI VENTURES
Chiesi Ventures is a venture capital firm that invests in early stage opportunities operating in the area of rare and orphan disorders. The company funds research and development opportunities for therapies of rare diseases and aims to improve the quality of diagnosis, disease management, care and therapy to all patients affected by rare diseases. It also aims to accelerate the expansion of the Chiesi network in the U.S. among universities, venture capital investors, rare disease patient organiz... ations, and entrepreneurial companies developing treatments for rare diseases. On September 2, 2014, Chiesi Ventures and A. M. Pappas & Associates announced a strategic collaboration. Chiesi Ventures was founded on September 2, 2014, and is headquartered in Parma, Italy with presence in the United States. It is owned by Chiesi Group.
CHIESI VENTURES
Industry:
Venture Capital
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro Google Apps For Business GStatic Google Static Content Google Cloud Sectigo SSL
Similar Organizations
Fort Ross Ventures
Fort Ross Ventures is a venture capital firm that invests in early growth stage startups with the proven product, technology.
HealthCare Ventures
HealthCare Ventures is a life science venture capital firm that invests in early clinical stage companies which transform patient care.
Mobius Venture Capital
Mobius Venture Capital is an early-stage venture capital fund that invests in various sectors, including healthcare and infrastructure.
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-06-23 | Glycomine | Chiesi Ventures investment in Series B - Glycomine | 35 M USD |
| 2021-03-22 | Aura Biosciences | Chiesi Ventures investment in Venture Round - Aura Biosciences | 80 M USD |
| 2020-12-09 | Reneo Pharmaceuticals | Chiesi Ventures investment in Series B - Reneo Pharmaceuticals | 95 M USD |
| 2020-06-16 | 4D Molecular Therapeutics | Chiesi Ventures investment in Series C - 4D Molecular Therapeutics | 75 M USD |
| 2019-08-07 | Glycomine | Chiesi Ventures investment in Series B - Glycomine | 33 M USD |
| 2018-11-07 | Mirum Pharmaceuticals | Chiesi Ventures investment in Series A - Mirum Pharmaceuticals | 120 M USD |
| 2018-10-17 | CuraSen Therapeutics | Chiesi Ventures investment in Series A - CuraSen Therapeutics | 54.5 M USD |
| 2018-10-01 | VelosBio | Chiesi Ventures investment in Series A - VelosBio | 58 M USD |
| 2018-09-26 | Minoryx Therapeutics | Chiesi Ventures investment in Series B - Minoryx Therapeutics | 21.3 M EUR |
| 2018-09-05 | 4D Molecular Therapeutics | Chiesi Ventures investment in Series B - 4D Molecular Therapeutics | 90 M USD |
More informations about "Chiesi Ventures"
Leadership Team | Chiesi Global Rare Diseases
In 2014, he founded Chiesi Ventures as a joint venture with Pappas Capital, an established life science venture capital fund, where he currently serves as Managing Partner. He serves as a …See details»
Chiesi Ventures - Crunchbase Investor Profile
Chiesi Ventures is a venture capital firm that invests in early stage opportunities operating in the area of rare and orphan disorders. The company funds research and development opportunities for therapies of rare diseases and aims to …See details»
Chiesi Ventures investment portfolio - PitchBook
Founded in 2014, Chiesi Ventures is the corporate venture capital arm of Chiesi Farmaceutici based in Boston, Massachusetts. The firm prefers to invest in seed, start-ups, and early-stage …See details»
Chiesi Ventures, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Chiesi Ventures, Inc. of Boston, MA. Get the latest business insights from Dun & Bradstreet.See details»
Chiesi Ventures | F6S
Chiesi Ventures is a VC firm focused on the area of rare & orphan disorders . Accelerators & Events . Startup Programs; Accelerators; Investment Funds; GAN Accelerators; Startup …See details»
Chiesi Ventures | Investor Profile and Startup Investments
Chiesi Ventures also aim to accelerate the expansion of the Chiesi network in the US among universities, venture capital investors, rare disease patient organizations and entrepreneurial …See details»
Chiesi Ventures Fund - Pappas Capital
Chiesi Ventures supports the advancement of high-quality research and development opportunities for therapies that can provide hope for patients and their families. Pappas …See details»
Investments – ChiesiVentures
Chiesi Ventures is a venture capital firm focused on the area of rare and orphan disorders. Contact info. BOSTON, MA One Boston Place, #4000 . Boston, MA 02109 (US) PARMA, …See details»
Chiesi Ventures - Investor in Boston, Massachusetts - Ask For …
Chiesi Ventures is a venture capital firm focused on the area of rare and orphan disorders. Our goal is to complement the strategic interest of the Chiesi Group by investing in early-stage …See details»
Chiesi Ventures, LP – Fund Data
Chiesi Ventures, LP is a venture capital fund operated by Pappas Ventures and has approximately $61.8 million in assets. The current minimum investment for Chiesi Ventures, …See details»
Chiesi Ventures - VC Firm Profile - Gaebler.com Venture Capital …
Chiesi Ventures makes VC investments in companies focused on high-impact, technology-driven solutions. Venture Investor Overview. Venture Investor. Chiesi Ventures. Status. InActive. …See details»
Chiesi Ventures Information - RocketReach
Chiesi Ventures is a venture capital firm focused on the area of rare and orphan disorders. Our goal is to complement the strategic interest of the Chiesi Group by investing in early stage …See details»
Team and Governance – ChiesiVentures
In 2014, he founded Chiesi Ventures as a joint venture with Pappas Capital. Before going back to the Chiesi Group, Giacomo was a consultant with Bain & Co, where he led teams in a variety …See details»
Chiesi Ventures - Investments, Portfolio & Company Exits
Chiesi Ventures 's most notable exits include Aura Biosciences, 4D Molecular Therapeutics, and Mirum Pharmaceuticals. Which industries has this organization had the most exits in? Show . …See details»
How one pharma “family business” places patients first
5 days ago In 2014, he founded Chiesi Ventures as a joint venture with Pappas Capital, an established life science venture capital fund, where he currently serves as Managing Partner. …See details»
Chiesi Ventures - Overview, CEO, Products, Business - Easyleadz
Chiesi Ventures is a private company and Chiesi Ventures is classified as a Non Government company. Chiesi Ventures is a Venture Capital & Private Equity based company and has …See details»
Investment Focus - ChiesiVentures
Chiesi Ventures focuses on creating a better world by investing in promising start-ups that provide services and treatments for rare diseases. ... c/o The Chiesi Group. Largo Belloli 11/A. 43122 …See details»
Strategic Connections – ChiesiVentures
Chiesi Ventures is a venture capital firm focused on the area of rare and orphan disorders. Contact info. BOSTON, MA One Boston Place, #4000 . Boston, MA 02109 (US) PARMA, …See details»
Portfolio Companies - ChiesiVentures
Chiesi Ventures invests in innovative biotech companies developing treatments for rare diseases. ... c/o The Chiesi Group. Largo Belloli 11/A. 43122 Parma, Italy. RESEARCH TRIANGLE …See details»
$190M Raised: Canada's Top 20 Moonshot Ventures™ of
2 days ago Canada’s Top 20 Moonshots Ventures™ of 2025 are shaped by the insight and leadership of NACO’s national member network. These organizations—spanning angel …See details»